The effect of recombinant human hepatocyte growth factor (h-rHGF), a potent mitogen for hepatocytes, was investigated in primary cultures of human hepatocytes. Here, we describe a series of experiments to investigate the kinetics of its mitogenic action, as well as its metabolic effects on cultured
Effects of the mycotoxin deoxynivalenol on human primary hepatocytes
✍ Scribed by Maika Königs; Gerald Schwerdt; Michael Gekle; Hans-Ulrich Humpf
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 762 KB
- Volume
- 52
- Category
- Article
- ISSN
- 1613-4125
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Toxic effects of the mycotoxin deoxynivalenol (DON) observed in animals range from diarrhea, vomiting, gastro‐intestinal inflammation to necrosis of several tissues. In the last years, DON has been tested in hepatocytes of several animal species for its cytotoxicity. However, these tests are limited to the use of animal cells. No studies using human hepatocytes are available. Further investigations with the human hepatocellular liver carcinoma cell line HepG2 might be limited due to the disadvantages of cell lines (e. g. immortalization, tumor derivation, longtime cultivation) and do not necessarily reflect the response of normal human cells. In order to overcome this problem and to be closer to the human situation, we studied the effect of DON in human primary hepatocytes and compared these data to the effects in the HepG2 cell line. Cell viability, apoptotic and necrotic cell death, albumin secretion and metabolic activity were determined. It could be demonstrated that DON has a distinct cytotoxic effect on human primary hepatocytes. Viability, protein content and albumin secretion were reduced in a dose‐dependent manner. The apoptotic key enzyme caspase‐3 was activated, while LDH release occurred only after long incubation time due to a secondary necrosis. Furthermore, we studied the metabolism of DON using LC‐MS/MS. DON was neither metabolized by primary hepatocytes cells nor by the HepG2 cell line.
📜 SIMILAR VOLUMES
Hepatic bile acid concentrations are elevated in chronic cholestasis because of reduced canalicular excretion and active ileal absorption of the fraction eliminated in the gut. Ursodeoxycholic acid (UDCA) reduces the intestinal absorption of endogenous bile acids, thereby diminishing the concentrati
## Abstract Biochanin A (BCA), a phytoestrogen present in plant food and herbal products, has been reported to have cancer‐preventive effects that may be mediated, in part, through effects on carcinogen metabolism. Our objective was to examine the effect of BCA on gene expression for drug‐metaboliz
Fumonisins are mycotoxins produced by Fusarium verticillioides. The toxic effects of fumonisin B 1 (FB 1 ) at the cellular level consist of a mixture of both necrosis and apoptosis. We studied the effect of FB 1 in human lung fibroblasts (NHLF) and human kidney epithelial cells (RPTEC) in primary cu
## Abstract Hepatocyte growth factor (HGF) also known as hepatopoietin A (HPTA) (Michalopoulos, FASEB J., 4:176–187, 1990) is a heparin‐binding growth factor whose characterization and tissue distribution have been reported elsewhere. This growth factor was recently cloned and its amino acid sequen
Although the ability of hormones and growth factors to stimulate DNA synthesis in rat hepatocytes has been investigated extensively, no such study of human hepatocytes has been reported. Here we describe a series of experiments to identify those factors that regulate human hepatocyte DNA synthesis i